| Current Price | $21.51 | Mkt Cap | $682.1M |
|---|---|---|---|
| Open | $21.25 | P/E Ratio | 0.00 |
| Prev. Close | $21.51 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $20.59 - $21.71 | Volume | 1,247,112 |
| 52-Wk Range | $18.15 - $95.98 | Avg. Daily Vol. | 1,116,644 |
| Current Price | $21.51 | Mkt Cap | $682.1M |
|---|---|---|---|
| Open | $21.25 | P/E Ratio | 0.00 |
| Prev. Close | $21.51 | Div. (Yield) | $0.00 (0.0%) |
| Daily Range | $20.59 - $21.71 | Volume | 1,247,112 |
| 52-Wk Range | $18.15 - $95.98 | Avg. Daily Vol. | 1,116,644 |
The best Bull and Bear pitches based on recency and number of recommendations.
Intercept up 23% premarket on positive OCA dataFeb. 19, 2019 7:43 AM ET|About: Intercept Pharmaceuticals (ICPT)|By: Douglas W. House, SA News EditorIntercept Pharmaceuticals (NASDAQ:ICPT) is up 23% premarket on light volume following its announcement… More
Company is too reliant on one drug and whether its lead drug gets approval as a treatment for NASH. However, that all changes if it does get approval.
Read the most recent pitches from players about ICPT.
Recs
Kentuckyfarmer
(80.37)
Submitted: 1/23/2021 2:29:31 PM :
Start Price:
$27.99
NASDAQ:ICPT Score:
-22.64
Revenue growth plus possibility of huge blockbuster drug approval on the horizon - NASH
Recs
TMFjimhalley
(52.49)
Submitted: 9/2/2020 10:47:32 AM :
Start Price:
$45.53
NASDAQ:ICPT Score:
+60.40
Company is too reliant on one drug and whether its lead drug gets approval as a treatment for NASH. However, that all changes if it does get approval.
Recs
egger88
(< 20)
Submitted: 4/19/2020 2:31:01 PM :
Start Price:
$74.67
NASDAQ:ICPT Score:
-96.79
this goes up and down in alot of volume
Find the members with the highest scoring picks in ICPT.
alkusari (< 20) Score: +443.87
The Score Leader is the player with the highest score across all their picks in ICPT.
|
Top Pick |
Member Name |
Member Rating |
Start Date |
Call |
Time Frame |
Start Price |
Stock Gain |
Index Gain |
Score | Commentary |
|---|---|---|---|---|---|---|---|---|---|---|
| jjc007007 | 71.36 | 2/5/2014 |
|
5Y | $296.00 | -92.73% | +117.52% | +210.25 | 0 Comment | |
| Halffrenzy | 26.23 | 1/10/2014 |
|
5Y | $438.98 | -95.10% | +108.42% | +203.52 | 0 Comment | |
| sinvestor | 53.44 | 1/14/2014 |
|
3M | $361.00 | -94.04% | +109.41% | +203.46 | 1 Comment | |
| vzwatmrk | < 20 | 1/10/2014 |
|
5Y | $455.50 | -95.28% | +108.00% | +203.28 | 0 Comment | |
| kevrose31 | 80.31 | 1/10/2014 |
|
1Y | $373.00 | -94.23% | +107.51% | +201.75 | 0 Comment | |
| kayakmastr | 89.68 | 1/13/2014 |
|
1Y | $339.87 | -93.67% | +107.78% | +201.46 | 0 Comment | |
| alexeysm | 32.84 | 1/13/2014 |
|
1Y | $339.87 | -93.67% | +107.78% | +201.46 | 0 Comment | |
| Figgie27 | < 20 | 1/13/2014 |
|
3M | $339.87 | -93.67% | +107.78% | +201.46 | 0 Comment | |
| Brandonrules | < 20 | 4/11/2014 |
|
5Y | $260.33 | -91.74% | +109.54% | +201.28 | 0 Comment | |
| IBDContrarian | 81.13 | 12/18/2012 |
|
5Y | $34.40 | -37.47% | +163.78% | +201.25 | 1 Comment |
See what the Wall Street professionals think, according to their public statements and filings.
